Mild-moderate Alzheimer's Disease
Neurology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
DP
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Daehwa PharmaceuticalDonepezil
AstraZenecaMEDI1814 for IV injection
Clinical Trials (2)
Total enrollment: 257 patients across 2 trials
Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
Start: Dec 2016Est. completion: Aug 2019180 patients
Phase 2Completed
SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.
Start: Feb 2014Est. completion: Sep 201677 patients
Phase 1Completed
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
11h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
11h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
11h ago
Director of Finance
CoMind
London, UK
11h ago
Electronics Engineering Manager
CoMind
London, UK
11h ago
Director of Information Technology
Zavation Medical Products
11h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space